These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31324723)

  • 41. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
    Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
    J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
    Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
    Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-interleukin-6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus.
    Liang B; Gardner DB; Griswold DE; Bugelski PJ; Song XY
    Immunology; 2006 Nov; 119(3):296-305. PubMed ID: 17067309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating Angiogenic T Cells and Their Subpopulations in Patients with Systemic Lupus Erythematosus.
    Miao J; Qiu F; Li T; Zhao P; Zhang K; Lv M; Wan J; Qi X; Zhu P
    Mediators Inflamm; 2016; 2016():2842143. PubMed ID: 27065298
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mycophenolic acid inhibits SLE-associated cytokine expression and promotes apoptosis of peripheral blood mononuclear cells from patients with systemic lupus erythematosus.
    Su DL; Wang HJ; Ji XH; Li YY; Xuan HB; Heng C; Li YF
    Acta Pharmacol Sin; 2006 Aug; 27(8):1051-7. PubMed ID: 16867258
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expansion of bone marrow IFN-alpha-producing dendritic cells in New Zealand Black (NZB) mice: high level expression of TLR9 and secretion of IFN-alpha in NZB bone marrow.
    Lian ZX; Kikuchi K; Yang GX; Ansari AA; Ikehara S; Gershwin ME
    J Immunol; 2004 Oct; 173(8):5283-9. PubMed ID: 15470074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. PD-1+CXCR5-CD4+T cells are correlated with the severity of systemic lupus erythematosus.
    Lin J; Yu Y; Ma J; Ren C; Chen W
    Rheumatology (Oxford); 2019 Dec; 58(12):2188-2192. PubMed ID: 31180450
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-programmed cell death 1 antibody reduces CD4+PD-1+ T cells and relieves the lupus-like nephritis of NZB/W F1 mice.
    Kasagi S; Kawano S; Okazaki T; Honjo T; Morinobu A; Hatachi S; Shimatani K; Tanaka Y; Minato N; Kumagai S
    J Immunol; 2010 Mar; 184(5):2337-47. PubMed ID: 20139271
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The
    Hagberg N; Joelsson M; Leonard D; Reid S; Eloranta ML; Mo J; Nilsson MK; Syvänen AC; Bryceson YT; Rönnblom L
    Ann Rheum Dis; 2018 Jul; 77(7):1070-1077. PubMed ID: 29475858
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of γδ T Cell Compartment Size to Disease Activity and Response to Therapy in SLE.
    Ma H; Yuan Y; Zhao L; Ye Z; Xu J; Li M; Jiang Z; Jiang Y
    PLoS One; 2016; 11(6):e0157772. PubMed ID: 27333282
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Targeting interferon-alpha: a promising approach for systemic lupus erythematosus therapy.
    Schmidt KN; Ouyang W
    Lupus; 2004; 13(5):348-52. PubMed ID: 15230291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sialic acid-binding immunoglobulin-type lectin H-positive plasmacytoid dendritic cells drive spontaneous lupus-like disease development in B6.Nba2 mice.
    Davison LM; Jørgensen TN
    Arthritis Rheumatol; 2015 Apr; 67(4):1012-22. PubMed ID: 25504931
    [TBL] [Abstract][Full Text] [Related]  

  • 53. IL-22+CD4+ T-cells in patients with active systemic lupus erythematosus.
    Zhao L; Jiang Z; Jiang Y; Ma N; Wang K; Zhang Y; Feng L
    Exp Biol Med (Maywood); 2013 Feb; 238(2):193-9. PubMed ID: 23576801
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased CD4
    Yin ZJ; Ju BM; Zhu L; Hu N; Luo J; He M; Feng XY; Lv XH; Pu D; He L
    Lupus; 2018 Nov; 27(13):2057-2068. PubMed ID: 30336752
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus.
    Nagy G; Pállinger E; Antal-Szalmás P; Aleksza M; Marschalkó M; Brózik M; Falus A; Gergely P
    Immunol Lett; 2000 Nov; 74(3):207-10. PubMed ID: 11064102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dysfunctional CD4+,CD25+ regulatory T cells in untreated active systemic lupus erythematosus secondary to interferon-alpha-producing antigen-presenting cells.
    Yan B; Ye S; Chen G; Kuang M; Shen N; Chen S
    Arthritis Rheum; 2008 Mar; 58(3):801-12. PubMed ID: 18311820
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased percentages of PD-1 on CD4+ T cells is associated with higher INF-γ production and altered IL-17 production in patients with systemic lupus erythematosus.
    Dolff S; Quandt D; Feldkamp T; Jun C; Mitchell A; Hua F; Specker C; Kribben A; Witzke O; Wilde B
    Scand J Rheumatol; 2014; 43(4):307-13. PubMed ID: 25088926
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression.
    Sugimoto K; Morimoto S; Kaneko H; Nozawa K; Tokano Y; Takasaki Y; Hashimoto H
    Autoimmunity; 2002 Sep; 35(6):381-7. PubMed ID: 12568118
    [TBL] [Abstract][Full Text] [Related]  

  • 59. IFN-γ licenses CD11b(+) cells to induce progression of systemic lupus erythematosus.
    Shaabani N; Honke N; Dolff S; Görg B; Khairnar V; Merches K; Duhan V; Metzger S; Recher M; Barthuber C; Hardt C; Proksch P; Häussinger D; Witzke O; Lang PA; Lang KS
    J Autoimmun; 2015 Aug; 62():11-21. PubMed ID: 26094774
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.